Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1996;89(Suppl 27):31–37.

Liver transplantation for hepatic cirrhosis in cystic fibrosis.

G Noble-Jamieson 1, N Barnes 1, N Jamieson 1, P Friend 1, R Calne 1
PMCID: PMC1295623  PMID: 8778448

Abstract

About 10% of children with CF develop hepatic cirrhosis and progressive portal hypertension. As the portal hypertension worsens these children are likely to develop serious variceal bleeding and other complications including malnutrition and a decline in respiratory function. Indices of lung function may fall as much as 50% in a year and chest infections may require frequent admissions to hospital. The respiratory symptoms are often attributed to CF related lung disease and affected children may therefore be considered unsuitable for liver transplantation. We propose a simple scoring system which can help to select patients who should be referred for assessment of liver transplantation. After careful assessment and preparation children with lung function indices as low as 30% predicted can have a successful outcome after liver transplantation. With good graft function portal hypertension is relieved and absorption, nutrition and respiratory function all improve. The improved quality of life of these children is remarkable.

Full text

PDF
31

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beath S. V., Brook G. D., Kelly D. A., Cash A. J., McMaster P., Mayer A. D., Buckels J. A. Successful liver transplantation in babies under 1 year. BMJ. 1993 Oct 2;307(6908):825–828. doi: 10.1136/bmj.307.6908.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cohn J. A., Strong T. V., Picciotto M. R., Nairn A. C., Collins F. S., Fitz J. G. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology. 1993 Dec;105(6):1857–1864. doi: 10.1016/0016-5085(93)91085-v. [DOI] [PubMed] [Google Scholar]
  3. Cole T. J., Freeman J. V., Preece M. A. Body mass index reference curves for the UK, 1990. Arch Dis Child. 1995 Jul;73(1):25–29. doi: 10.1136/adc.73.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colombo C., Apostolo M. G., Ferrari M., Seia M., Genoni S., Giunta A., Sereni L. P. Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr. 1994 Mar;124(3):393–399. doi: 10.1016/s0022-3476(94)70361-2. [DOI] [PubMed] [Google Scholar]
  5. Colombo C., Castellani M. R., Balistreri W. F., Seregni E., Assaisso M. L., Giunta A. Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Hepatology. 1992 Apr;15(4):677–684. doi: 10.1002/hep.1840150421. [DOI] [PubMed] [Google Scholar]
  6. Corris P. A. Post heart/lung transplantation management. J R Soc Med. 1995;88 (Suppl 25):37–40. [PMC free article] [PubMed] [Google Scholar]
  7. Cotting J., Lentze M. J., Reichen J. Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut. 1990 Aug;31(8):918–921. doi: 10.1136/gut.31.8.918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Feigelson J., Anagnostopoulos C., Poquet M., Pecau Y., Munck A., Navarro J. Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up. Arch Dis Child. 1993 May;68(5):653–657. doi: 10.1136/adc.68.5.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fewtrell M. S., Noble-Jamieson G., Revell S., Valente J., Friend P., Johnston P., Rasmussen A., Jamieson N., Calne R. Y., Barnes N. D. Intrapulmonary shunting in the biliary atresia/polysplenia syndrome: reversal after liver transplantation. Arch Dis Child. 1994 Jun;70(6):501–504. doi: 10.1136/adc.70.6.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Frisancho A. R. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981 Nov;34(11):2540–2545. doi: 10.1093/ajcn/34.11.2540. [DOI] [PubMed] [Google Scholar]
  11. Konstan M. W., Byard P. J., Hoppel C. L., Davis P. B. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995 Mar 30;332(13):848–854. doi: 10.1056/NEJM199503303321303. [DOI] [PubMed] [Google Scholar]
  12. Lebenthal E. High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better". J Pediatr Gastroenterol Nutr. 1994 May;18(4):423–425. doi: 10.1097/00005176-199405000-00002. [DOI] [PubMed] [Google Scholar]
  13. Lindblad A., Hultcrantz R., Strandvik B. Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis. Hepatology. 1992 Aug;16(2):372–381. doi: 10.1002/hep.1840160215. [DOI] [PubMed] [Google Scholar]
  14. Mieles L. A., Orenstein D., Teperman L., Podesta L., Koneru B., Starzl T. E. Liver transplantation in cystic fibrosis. Lancet. 1989 May 13;1(8646):1073–1073. doi: 10.1016/s0140-6736(89)92464-1. [DOI] [PubMed] [Google Scholar]
  15. Noble-Jamieson G., Valente J., Barnes N. D., Friend P. J., Jamieson N. V., Rasmussen A., Calne R. Y. Liver transplantation for hepatic cirrhosis in cystic fibrosis. Arch Dis Child. 1994 Oct;71(4):349–352. doi: 10.1136/adc.71.4.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rosenstein B. J., Eigen H. Risks of alternate-day prednisone in patients with cystic fibrosis. Pediatrics. 1991 Feb;87(2):245–246. [PubMed] [Google Scholar]
  17. Salt A., Noble-Jamieson G., Barnes N. D., Mowat A. P., Rolles K., Jamieson N., Johnston P., Friend P., Calne R. Y. Liver transplantation in 100 children: Cambridge and King's College Hospital series. BMJ. 1992 Feb 15;304(6824):416–421. doi: 10.1136/bmj.304.6824.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Scott-Jupp R., Lama M., Tanner M. S. Prevalence of liver disease in cystic fibrosis. Arch Dis Child. 1991 Jun;66(6):698–701. doi: 10.1136/adc.66.6.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tanner M. S. Liver and biliary problems in cystic fibrosis. J R Soc Med. 1992;85 (Suppl 19):20–24. [PMC free article] [PubMed] [Google Scholar]
  20. Thomson A. H. Human recombinant DNase in cystic fibrosis. J R Soc Med. 1995;88 (Suppl 25):24–29. [PMC free article] [PubMed] [Google Scholar]
  21. Weizman Z., Durie P. R., Kopelman H. R., Vesely S. M., Forstner G. G. Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption. Gut. 1986 Sep;27(9):1043–1048. doi: 10.1136/gut.27.9.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Williams S. G., Westaby D. Management of variceal haemorrhage. BMJ. 1994 May 7;308(6938):1213–1217. doi: 10.1136/bmj.308.6938.1213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Worthy S. High resolution computed tomography of the lungs. BMJ. 1995 Mar 11;310(6980):615–616. doi: 10.1136/bmj.310.6980.616. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES